Abstract:The development of near-infrared (NIR) laser triggered phototheranostics for multimodal imaging-guided combination therapy is highly desirable. However, multiple laser sources, as well as inadequate therapeutic efficacy, impede the application of phototheranostics. Here, we develop an all-in-one theranostic nanoagent PEGylated x NPs (DCDMs) with a flower-like structure fabricated by coating uniformly sized down-conversion nanoparticles (DCNPs) with dendritic mesoporous silica (DMSN) and then loading the ultrasmall oxygen-deficient molybdenum oxide nanoparticles (MoOx NPs) inside through an electrostatic interaction. Owing to the doping of Nd ions, when excited by an 808 nm laser, DCNPs emit bright NIR-II emissions (1060 and 1300 nm), which have characteristic high spatial resolution and deep tissue penetration. In terms of treatment, MoOx NPs could be specifically activated by excessive hydrogen peroxide (H2O2) in the tumor microenvironment, thus generating 1O2via the Russell mechanism. In addition, the excessive glutathione (GSH) in the tumor cells could be depleted through the Mo-mediated redox reaction, thus effectively decreasing the antioxidant capacity of tumor cells. Importantly, the excellent photothermal properties (photothermal conversion efficiency of 51.5% under an 808 nm laser) synergistically accelerate the generation of 1O2. This cyclic redox reaction of molybdenum indeed ensured the high efficacy of tumor-specific therapy, leaving the normal tissues unharmed. MoOx NPs could also efficiently catalyze tumor endogenous H2O2 into a considerable amount of O2 in an acidic tumor microenvironment, thus relieving hypoxia in tumor tissues. Moreover, the computed tomography (CT) and T1-weighted magnetic resonance imaging (MRI) effect from Gd3+ and Y3+ ions make DCNPs act as a hybrid imaging agent, allowing comprehensive analysis of tumor lesions. Both in vitro and in vivo experiments validate that such an "all-in-one" nanoplatform possesses desirable anticancer abilities under single laser source irradiation, benefiting from the NIR-II fluorescence/CT/MR multimodal imaging-guided photothermal/chemodynamic synergistic therapy. Overall, our strategy paves the way to explore other noninvasive cancer phototheranostics.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acsami.0c17923?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acsami.0c17923</a>.Experimental methods, HRTEM images, XRD patterns, N2 adsorption–desorption isotherms, pore size distribution, extinction coefficient, photostability and colloidal stability, ESR spectra, schematic illustration of the Russell mechanism, oxygen generation, cell viability, line profiles of CT and MRI values, photothermal behavior under a 1064 nm laser, digital photo of tumors harvested from different groups, H&E stained photographs of major organs, and TEM images of DCDMs after biodegradation (<a class="ext-link" href="/doi/suppl/10.1021/acsami.0c17923/suppl_file/am0c17923_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

Nir-Activated Spatiotemporally Controllable Nanoagent For Achieving Synergistic Gene-Chemo-Photothermal Therapy In Tumor Ablation

Tlyp-1-conjugated Au-nanorod@SiO(2) Core-Shell Nanoparticles for Tumor-Targeted Drug Delivery and Photothermal Therapy.

Engineered, Self-Assembled Near-Infrared Photothermal Agents for Combined Tumor Immunotherapy and Chemo-Photothermal Therapy

Tumor-Microenvironment-Activatable Nanoreactor Based on a Polyprodrug for Multimodal-Imaging-Medicated Enhanced Cancer Chemo/Phototherapy

Multi-stimuli-Responsive and Cell Membrane Camouflaged AIE Nanogels for Precise Chemo-Photothermal Synergistic Therapy of Tumors

Gold Nanorods-Based Smart Nanoplatforms for Synergic Thermotherapy and Chemotherapy of Tumor Metastasis

Multi-Stimuli-Responsive and Cell Membrane Camouflaged Aggregation-Induced Emission Nanogels for Precise Chemo-photothermal Synergistic Therapy of Tumors

pH-Controlled Intracellular in Situ Reversible Assembly of a Photothermal Agent for Smart Chemo-Photothermal Synergetic Therapy and ATP Imaging

A Spatiotemporally Controlled Gene‐Regulation Strategy for Combined Tumor Therapy Based on Upconversion Hybrid Nanosystem

In vivo Imaging-Guided Nanoplatform for Tumor Targeting Delivery and Combined Chemo-, Gene- and Photothermal Therapy.

Facile Fabrication Of A Near-Infrared Responsive Nanocarrier For Spatiotemporally Controlled Chemo-Photothermal Synergistic Cancer Therapy

Multifunctional hierarchical nanohybrids perform triple antitumor theranostics in a cascaded manner for effective tumor treatment

pH-Controlled Intracellular in Situ Reversible Assembly of Photothermal Agent for Smart Chemo-Photothermal Synergetic Therapy and ATP Imaging.

Near Infrared-Guided Smart Nanocarriers for MicroRNA-Controlled Release of Doxorubicin/siRNA with Intracellular ATP As Fuel.

Multimode Imaging-Guided Photothermal/Chemodynamic Synergistic Therapy Nanoagent with a Tumor Microenvironment Responded Effect

High Performance Gold Nanorods@DNA Self-Assembled Drug-Loading System for Cancer Thermo-Chemotherapy in the Second Near-Infrared Optical Window

Tumor-Targeted and Enzyme-Responsive Gold Nanorod-based Nanoplatform with Facilitated Endo-lysosomal Escape for Synergetic Photothermal Therapy and Protein Therapy

An NIR-Guided Aggregative and Self-Immolative Nanosystem for Efficient Cancer Targeting and Combination Anticancer Therapy.

Nir-Triggered Chemo-Photothermal Therapy By Thermosensitive Gold Nanostar@Mesoporous Silica@Liposome-Composited Drug Delivery Systems

Tumor acidity activating multifunctional nanoplatform for NIR-mediated multiple enhanced photodynamic and photothermal tumor therapy

NIR-activated Janus Nanomotors with Promoted Tumor Permeability for Synergistic Photo-Immunotherapy